Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01751607 · ClinicalTrials.gov registry record
Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF)
A clinical trial, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- Completed
- Registry status
- 400
- Enrollment target
NCT01751607: Completed study, sponsored by Texas Cardiac Arrhythmia Research Foundation.
NCT01751607 is a clinical trial that has completed, run by Texas Cardiac Arrhythmia Research Foundation. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01751607 has completed, sponsored by Texas Cardiac Arrhythmia Research Foundation.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
Study Summary
This prospective study aims to examine the association of specific genetic variants (single nucleotide polymorphisms) located on chromosome 1, 4 and 16, with presence of non-pulmonary vein triggers (NPVT) as well as ablation-outcome in AF patients
Primary Outcome
Isolation of pulmonary-vein antra and all extra-pulmonary vein triggers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-08 |
What the finished NCT01751607 record still lists
NCT01751607 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01751607 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01751607 about?
NCT01751607 is a clinical study titled "Determining the Association of Chromosomal Variants With Non-PV Triggers and Ablation-outcome in AF (DECAF)". This prospective study aims to examine the association of specific genetic variants (single nucleotide polymorphisms) located on chromosome 1, 4 and 16, with presence of non-pulmonary vein triggers (NPVT) as well as ablation-outcome in AF patients
What is the current status of trial NCT01751607?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2012-12. Estimated completion is 2014-08.
Who is sponsoring clinical trial NCT01751607?
This trial is sponsored by Texas Cardiac Arrhythmia Research Foundation, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia